The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19.

Marcos Pereira ; Enny Paixão ORCID logo ; Anete Trajman ; Ramon Andrade de Souza ; Marcio Santos da Natividade ; Julia M Pescarini ORCID logo ; Susan Martins Pereira ; Florisneide Rodrigues Barreto ; Ricardo Ximenes ; Margareth Dalcomo ; +4 more... Maria Yury Ichihara ; Ceuci Nunes ; Manoel Barral-Netto ; Maurício L Barreto ; (2020) The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19. RESPIRATORY RESEARCH, 21 (1). 178-. ISSN 1465-9921 DOI: 10.1186/s12931-020-01439-4
Copy

Bacillus Calmette-Guérin (BCG) vaccination is routine and near-universal in many low- and middle-income countries (LMIC). It has been suggested that BCG can have a protective effect on COVID-19 morbidity and mortality. This commentary discusses the limitations of the evidence around BCG and COVID-19. We argue that higher-quality evidence is necessary to understand the protective effect of the BCG vaccine from existing, secondary data, while we await results from clinical trials currently conducted in different settings.
Item Type Article
Elements ID 150968
Date Deposited 15 Oct 2020 16:00

Explore Further

picture_as_pdf
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19.pdf
subject
Published Version
Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0
View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads